Other Assets, Noncurrent in USD of RELMADA THERAPEUTICS, INC. from Q2 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Relmada Therapeutics, Inc. quarterly Other Assets, Noncurrent history and change rate from Q2 2015 to Q3 2025.
  • Relmada Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $22K, unchanged year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

RELMADA THERAPEUTICS, INC. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $22K $0 0% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $22K -$31.7K -59% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $22K -$21.2K -49% 31 Mar 2025 10-Q 12 May 2025
Q4 2024 $22K -$21.2K -49% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 $22K -$25.7K -53.9% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $53.6K +$19K +55% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 $43.1K +$8.25K +23.7% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $43.1K +$8.25K +23.7% 31 Dec 2023 10-K 27 Mar 2025
Q3 2023 $47.7K +$31.6K +196% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $34.6K -$648 -1.84% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $34.9K +$6.58K +23.3% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $34.9K +$6.58K +23.3% 31 Dec 2022 10-K 19 Mar 2024
Q3 2022 $16.1K -$8.91K -35.6% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $35.2K +$10.2K +41% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $28.3K +$3.29K +13.2% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $28.3K +$3.29K +13.2% 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 $25K $0 0% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $25K $0 0% 30 Jun 2021 10-Q 10 Aug 2021
Q1 2021 $25K $0 0% 31 Mar 2021 10-Q 12 May 2021
Q4 2020 $25K $0 0% 31 Dec 2020 10-K 25 Mar 2022
Q3 2020 $25K $0 0% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 $25K $0 0% 30 Jun 2020 10-Q 12 Aug 2020
Q1 2020 $25K -$18.9K -43.1% 31 Mar 2020 10-Q 15 May 2020
Q4 2019 $25K +$6.09K +32.2% 31 Dec 2019 10-K 24 Mar 2021
Q3 2019 $25K +$6.09K +32.2% 30 Sep 2019 10-Q 13 Nov 2019
Q2 2019 $25K +$212 +0.86% 30 Jun 2019 10-K 24 Mar 2021
Q1 2019 $43.9K +$22.3K +103% 31 Mar 2019 10-Q 15 May 2019
Q4 2018 $18.9K -$3.05K -13.9% 31 Dec 2018 10-Q 13 Feb 2019
Q3 2018 $18.9K -$3.05K -13.9% 30 Sep 2018 10-Q 13 Nov 2018
Q2 2018 $24.8K +$2.83K +12.9% 30 Jun 2018 10-KT 26 Mar 2020
Q1 2018 $21.6K -$393K -94.8% 31 Mar 2018 10-Q 14 May 2018
Q4 2017 $22K -$393K -94.7% 31 Dec 2017 10-Q 12 Feb 2018
Q3 2017 $22K -$393K -94.7% 30 Sep 2017 10-Q 14 Nov 2017
Q2 2017 $22K -$392K -94.7% 30 Jun 2017 10-K 28 Sep 2018
Q1 2017 $415K +$2.22K +0.54% 31 Mar 2017 10-Q 15 May 2017
Q4 2016 $415K 31 Dec 2016 10-Q 10 Feb 2017
Q3 2016 $415K 30 Sep 2016 10-Q 10 Nov 2016
Q2 2016 $414K +$13.5K +3.38% 30 Jun 2016 10-K 28 Sep 2017
Q1 2016 $413K 31 Mar 2016 10-Q 09 May 2016
Q2 2015 $401K 30 Jun 2015 10-K 09 Sep 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.